Jump to content

IBS Patient Group Advocacy at the FDA

Jeffrey Roberts

Recommended Posts

Jeffrey Roberts


Last month the US Food and Drug Administration advisory committee voted to recommend reintroduction of Zelnorm for IBS-C and for the new medication Prucalopride for chronic constipation. The IBS Patient Group provided in-person testimony at the committee meetings.

Read our testimonies at https://www.ibspatient.org/advocacy

Link to comment
Share on other sites

  • Jeffrey Roberts changed the title to IBS Patient Group Advocacy at the FDA

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...